At the close in Stockholm, the OMX Stockholm 30 lost 1.01%. The best performers of the session on the OMX Stockholm 30 were AstraZeneca PLC (ST:AZN), which rose 1.86% or 25.50 points to trade at ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Stocks on Sweden's OMX Stockholm 30 Index rose 0.3%, while Norway's Oslo Exchange Benchmark Index_GI declined 0.4%. Shares in Iceland increased, with the OMX Iceland All-Share PI Equity Index ...
Moberg Pharma AB (OMX: MOB) and Allderma today announce that the launch of Terclara® (MOB-015) is ongoing in Norway. The launch marks an important step in both companies' commercial strategy and ...
At the close in Stockholm, the OMX Stockholm 30 declined 0.85% to hit a new 1-month low. The best performers of the session on the OMX Stockholm 30 were Svenska Cellulosa SCA AB B (ST:SCAb), which ...
Ich bin damit einverstanden, dass mir die BurdaForward GmbH, St. Martin Straße 66, 81541 München, regelmäßig News zu den oben ausgewählten Themenbereichen per E-Mail zusendet. Ich bin ...
T. Rowe Price head of global multi-asset and chief investment officer Sébastien Page joins Julie Hyman on Market Domination Overtime to discuss why he favors value stocks. Page notes that while ...